These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27437182)

  • 1. Add-on perampanel in Lance-Adams syndrome.
    Steinhoff BJ; Bacher M; Kurth C; Staack AM; Kornmeier R
    Epilepsy Behav Case Rep; 2016; 6():28-9. PubMed ID: 27437182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of perampanel in a patient with epilepsia partialis continua.
    Argente-Escrig H; Gómez-Ibáñez A; Villanueva V
    Epilepsy Behav Case Rep; 2017; 8():105-107. PubMed ID: 29062692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects].
    Saito K; Oi K; Inaba A; Kobayashi M; Ikeda A; Wada Y
    Rinsho Shinkeigaku; 2021 Jan; 61(1):18-23. PubMed ID: 33328418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus.
    Mir A; Alghamdi A; Alotaibi W; Samreen D; Alotaibi M; Albaradie R; Bashir S
    Epileptic Disord; 2022 Aug; 24(4):633-646. PubMed ID: 35770766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures.
    Besag FM; Patsalos PN
    Neuropsychiatr Dis Treat; 2016; 12():1215-20. PubMed ID: 27274257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).
    Schorlemmer K; Bauer S; Belke M; Hermsen A; Klein KM; Reif PS; Oertel WH; Kunz WS; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav Case Rep; 2013; 1():118-21. PubMed ID: 25667843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.
    Steinhoff BJ
    Ther Adv Neurol Disord; 2015 May; 8(3):137-47. PubMed ID: 25941541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 11. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.
    Rohracher A; Brigo F; Höfler J; Kalss G; Neuray C; Dobesberger J; Kuchukhidze G; Leitinger M; Trinka E
    Expert Opin Pharmacother; 2016 Jul; 17(10):1403-11. PubMed ID: 27267634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perampanel: A Review in Drug-Resistant Epilepsy.
    Frampton JE
    Drugs; 2015 Sep; 75(14):1657-68. PubMed ID: 26370209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perampanel: What is its Place in the Management of Partial Onset Epilepsy?
    Ledingham DR; Patsalos PN
    Neurol Ther; 2013 Dec; 2(1-2):13-24. PubMed ID: 26000213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
    Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M
    Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report.
    Chowdhury D; McCarthy C
    Clin Neuropharmacol; 2024 Jul-Aug 01; 47(4):134-139. PubMed ID: 39008544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effectiveness of Perampanel for Myoclonic Seizures in Down Syndrome with Isodicentric Chromosome 21.
    Obara K; Imota T; Mamiya S; Toyoshima I
    Case Rep Neurol; 2020; 12(3):270-275. PubMed ID: 33082764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Tahara M; Higurashi N; Narita A; Ida H
    Brain Dev; 2022 Apr; 44(4):308-312. PubMed ID: 34991910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perampanel in lissencephaly-associated epilepsy.
    Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Koichihara R
    Epilepsy Behav Case Rep; 2019; 11():67-69. PubMed ID: 30723672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report.
    Chowdhury D; McCarthy C
    Clin Neuropharmacol; 2024 Jun; ():. PubMed ID: 38976254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.